Literature DB >> 17176056

Structural requirements of FGF-1 for receptor binding and translocation into cells.

Malgorzata Zakrzewska1, Daniel Krowarsch, Antoni Wiedlocha, Sjur Olsnes, Jacek Otlewski.   

Abstract

FGF-1 binds to and activates specific transmembrane receptors (FGFRs) and is subsequently internalized and translocated to the interior of the cell. To elucidate the role of the receptor in the translocation process, we studied the effects of the elimination of distinct sites of the ligand-receptor interaction. On the basis of the structure of the FGF-1-FGFR1 complex, we substituted four key amino acid residues of FGF-1 from the FGF-receptor binding site with alanines, constructing four point mutants and one double mutant. We determined by in vivo assays in NIH 3T3 cells the ability of the mutants to bind to specific FGF receptors, to stimulate DNA synthesis, and to activate downstream signaling pathways. We found that correct binding to the receptor is necessary for optimal stimulation of DNA synthesis. All four single mutants became phosphorylated to different extents, indicating that they were translocated to the cytosol/nucleus with varying efficiency. This indicates that despite a low affinity for FGFR, translocation to the cytosol/nucleus can still occur. However, simultaneous substitution in two of the positions led to a total loss of biological activity of the growth factor and prevented its internalization, implying that there is only one strongly receptor-dependent, productive way of translocating FGF-1. We also found that the process of translocation did not correlate with the thermal stability of the protein. Additionally, we observed a clear negative correlation between the stability of the FGF-1 mutants and the efficiency of their phosphorylation, which strongly suggests that protein kinases prefer the unfolded state of the protein substrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176056     DOI: 10.1021/bi0618114

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity.

Authors:  Julia Chudzian; Anna Szlachcic; Malgorzata Zakrzewska; Miroslawa Czub; Marcin Pustula; Tad A Holak; Jacek Otlewski
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

2.  FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner.

Authors:  Martyna Sochacka; Lukasz Opalinski; Jakub Szymczyk; Marta B Zimoch; Aleksandra Czyrek; Daniel Krowarsch; Jacek Otlewski; Malgorzata Zakrzewska
Journal:  Cell Commun Signal       Date:  2020-05-01       Impact factor: 5.712

3.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.